Skip to main content
Publications
Forns J , Dudukina E, Hagg D, Szentkuti P, Gembert K, Plana E , Gilsenan A , Horvath-Puho E, Ehrenstein V, Reutfors J, Rebordosa C . Risk of major cardiovascular and cerebrovascular events in users of lisdexamfetamine and other medications for attention-deficit/hyperactivity disorder in Denmark and Sweden: a population-based cohort study . Neurol Ther. 2022 Dec 1;11(4):1659-76. doi: 10.1007/s40120-022-00396-y
Forns J , Dudukina E, Hagg D, Szentkuti EP, Gembert K, Plana E , Gilsenan A , Horvath-Puho E, Reutfors J, Rebordosa C . Cohort study of the incidence of major cardiovascular events in new adult users of lisdexamfetamine and remote adult users of other attention-deficit/hyperactivity disorder treatments . Poster presented at the 2021 8th World Congress on ADHD Virtual Event; May 6, 2021.
Lenters V, Iszatt N, Forns J , Cechova E, Kocan A, Legler J, Leonards P, Stigum H, Eggesbo M. Early-life exposure to persistent organic pollutants (OCPs, PBDEs, PCBs, PFASs) and attention-deficit/hyperactivity disorder: a multi-pollutant analysis of a Norwegian birth cohort . Environ Int. 2019 Apr;125:33-42. doi: 10.1016/j.envint.2019.01.020
Forns J , Sunyer J, Garcia-Esteban R , Porta D, Ghassabian A, Giorgis-Allemand L, Gong T, Gehring U, Sorensen M, Standl M, Sugiri D, Almqvist C, Andiarena A, Baldaloni C, Beelen R, Berdel D, Cesaroni G, Charles MA, Eriksen KT, Estarlich M, Fernandez MF, Forhan A, Jaddoe VWV, Korek M, Lichtenstein P, Lertxundi A, Lopez-Espinosa MJ, Markevych I, de Nazelle A, Raaschou-Nielsen O, Nieuwenhuijsen M, Perez-Lobato R, Philippat C, Slama R, Tiesler CM, Verhulst FC, von Berg A, Vrijkotte T, Nybo Andersen AM, Heude B, Kramer U, Heinrich J, Tiemeier H, Forastiere F, Pershagen G, Brunekreef B, Guxens M. Air pollution exposure during pregnancy and symptoms of attention deficit and hyperactivity disorder in children in Europe . Epidemiology. 2018 Sep;29(5):618-26. doi: 10.1097/EDE.0000000000000874
Forns J , Stigum H, Hoyer BB, Sioen I, Sovcikova E, Nowack N, Lopez-Espinosa MJ, Guxens M, Ibarluzea J, Torrent M, Wittsiepe J, Govarts E, Trnovec T, Chevrier C, Toft G, Vrijheid M, Iszatt N, Eggesbo M. Prenatal and postnatal exposure to persistent organic pollutants (POPs) and attention-deficit and hyperactivity disorder (ADHD): a pooled analysis of seven European birth cohort studies . Int J Epidemiol. 2018 Aug;47(4):1082-97. doi: 10.1093/ije/dyy052
Mortamais M, Pujol J, van Drooge BL, Macia D, Martinez-Vilavella G, Reynes C, Sabatier R, Rivas I, Grimalt J, Forns J , Alvarez-Pedrerol M, Querol X, Sunyer J. Effect of exposure to polycyclic aromatic hydrocarbons on basal ganglia and attention-deficit hyperactivity disorder symptoms in primary school children . Environ Int. 2017 Aug;105:12-9. doi: 10.1016/j.envint.2017.04.011
Suades-Gonzalez E, Forns J , Garcia-Esteban R , Lopez-Vicente M, Esnaola M, Alvarez-Pedrerol M, Julvez J, Caceres A, Basagana X, Lopez-Sala A, Sunyer J. A longitudinal study on attention development in primary school children with and without teacher-reported symptoms of ADHD . Front Psychol. 2017 May 16;8:655. doi: 10.3389/fpsyg.2017.00655
Quteineh L, Preisig M, Rivera M, Milaneschi Y, Castelao E, Gholam-Rezaee M, Vandenberghe F, Saigi-Morgui N , Delacretaz A, Cardinaux JR, Willemsen G, Boomsma DI, Penninx BW, Ching-Lopez A, Conus P, Eap CB. Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression . J Affect Disord. 2016 Jul;198:43-9. doi: 10.1016/j.jad.2016.03.031
Vandenberghe F, Gholam-Rezaee M, Saigi-Morgui N , Delacretaz A, Choong E, Solida-Tozzi A, Kolly S, Thonney J, Gallo SF, Hedjal A, Ambresin AE, von Gunten A, Conus P, Eap CB. Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment . J Clin Psychiatry. 2015 Nov;76(11):e1417-23. doi: 10.4088/JCP.14m09358.
Delacretaz A, Preisiq M, Vandenberghe F, Saigi Morgui N , Quteineh L, Choong E, Gholam-Rezaee M, Kutalik Z, Magistretti P, Aubry JM, von Gunten A, Castelao E, Vollenweider P, Waeber G, Conus P, Eap CB. Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in population-based subjects with present or past atypical depression . PLoS One. 2015 Oct 13;10(10):e0139155. doi: 10.1371/journal.pone.0139155
Saigi-Morgui N , Vandenberghe F, Delacretaz A, Quteineh L, Choong E, Gholamrezaee M, Magistretti P, Aubry JM, von Gunten A, Preisig M, Castelao E, Vollenweider P, Waeber G, Kutalik Z, Conus P, Eap CB. Association of PCK1 with body mass index and other metabolic features in patients with psychotropic treatments . J Clin Psychopharmacol. 2015 Oct;35(5):544-52. doi: 10.1097/JCP.0000000000000388
Delacretaz A, Preisig M, Vandenberghe F, Saigi-Morgui N , Quteineh L, Choong E, Gholamrezaee M, Kutalik Z, von Gunten A, Castelao E, Vollenweider P, Conus P, Eap C. Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in subjects from the general population with present or past atypical depression . Presented at the 2015 World Congress of Biological Psychiatry; June 18, 2015. Athens, Greece.
Saigi-Morgui N , Vandenberghe F, Delacretaz A, Quteineh L, Gholamrezaee M, Kutalik Z, Aubry JM, von Gunten A, Conus P, Eap C. Influence of weighted genetic risk score on BMI in Swiss psychiatric cohorts . Presented at the 2015 World Congress of Biological Psychiatry; June 14, 2015. Athens, Greece.
Quteineh L, Vandenberghe F, Saigi-Morgui N , Delacretaz A, Choong E, Gholamrezaee M, von Gunten A, Preisig M, Castelao E, Vollenweider P, Kutalik Z, Conus P, Eap C. Impact of HSD11B1 polymorphisms on body mass index and components of the metabolic syndrome in patients with psychotropic treatments . Presented at the 2015 World Congress of Biological Psychiatry; June 2015. Athens, Greece.
Quteineh L, Vandenberghe F, Saigi Morgui N , Delacretaz A, Choong E, Gholam-Rezaee M, Magistretti P, Bondolfi G, von Gunten A, Preisig M, Castelao E, Vollenweider P, Waeber G, Bochud M, Kutalik Z, Conus P, Eap CB. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments . Pharmacogenet Genomics. 2015 May;25(5):246-58. doi: 10.1097/FPC.0000000000000131
Quteineh L, Vandenberghe F, Gholam Rezaee M, Choong E, Saigi-Morgui N , Delacretaz A, Preisig M, von Gunten A, Conus P, Eap C. CRTC3 polymorphisms are not associated with obesity in Swiss psychiatric populations . Poster presented at the 22nd European Congress of Psychiatry; March 2014. Munich, Germany. [abstract] The european journal of psychiatry. 2014; 29:1.